Lates News

Ironwood Pharmaceuticals (IRWD.US): In the third quarter of 2025, revenue reached $1.221 billion, compared to $915.92 million in the previous period, and an expected value of $728.12 million; earnings per share were $0.24, compared to $0.02 in the previous period, and an expected value of $0.11.